Approval · Notice of Compliance 23743 · 2020
COMBOGESIC: Notice of Compliance 23743
Issued June 5, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23743
- Date
- June 5, 2020
- Company
- BioSyent Pharma Inc.Mississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Addition of labelling material for a new package size, Change in labelling design and graphics in compliance with the Plain Language Labelling requirements
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COMBOGESIC | 02488280 | Marketed |
Medicinal ingredients
- ACETAMINOPHEN 325 MG per TAB
- IBUPROFEN 97.5 MG per TAB